RENASANT CORP 4

4 · RENASANT CORP · Filed Feb 5, 2007

Form 4

Period: 2007-02-01

Sr. Executive Vice President

Transactions

Holdings

Stock Options (Right to Buy)
Exercise: $15.65From: 2003-01-01Exp: 2012-01-01→ Common Stock (7,875 underlying)
7,875
Common Stock
(indirect: By Spouse)
1,975
Common Stock
(indirect: By Trust)
3,430
Common Stock
(indirect: By Trust)
4,350
Common Stock
(indirect: By 401(k))
15,971.395
Stock Options (Right to Buy)
Exercise: $30.63From: 2008-01-01Exp: 2017-01-01→ Common Stock (7,500 underlying)
7,500
Common Stock
(indirect: By IRA)
5,443
Common Stock (Restricted Stock)
1,500
Phantom Stock
→ Common Stock (7,500 underlying)
2,737.47

Footnotes (4)

[F1]This is the target amount of a performance based restricted stock grant available at the en fof the 2007 Performance Cycle if certain performance criteria is met. Any adjustments to the Target Award (whether an increase or decrease) will be reported at the time of the actual detrmination of performance as compared to the applicable threshold, target and maximum Performance Objectives. In no event, however, will the number of shares awarded exceed 150% of the number of shares of the target award. Share price will be determined on the last business day prior to the end of the performance cycle.
[F2]The phantom stock units are accrued under the Renasant DSU Plan. The units are settled 100% in the Company's common stock upon the reporting person's retirement or upon approved hardship reasons. The conversion price is one phantom stock unit for one share of the Company's common stock.
[F3]Beginning with this date, equal installments of 33 1/3 of the option shares granted will be available for exercise upon completion of one, two, and three years service measured from date of grant, respectively. The options expire ten 10 years from the grant date.
[F4]This is the adjustment to the target amount of the 2006 performance based restricted stock grant previously reported.

Documents

1 file